Ken Hagiwara
Nihon University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ken Hagiwara.
Journal of Veterinary Medical Science | 2018
Hiroo Kanai; Ken Hagiwara; Aya Nukaya; Motoki Kondo; Akihide Aso
Laparoscopic cholecystectomy (LC) is widely accepted as the standard treatment for benign gall bladder diseases in humans because it has proven to be less invasive and safer than are traditional methods. However, the efficacy of LC in dogs remains unclear. The present study aimed to examine the short-term outcome of LC for benign gall bladder diseases in dogs. We enrolled 76 consecutive dogs that underwent LC for benign gall bladder diseases at our hospital between April 2008 and October 2016. Dogs with jaundice, gall bladder ruptures, abdominal effusion, or extrahepatic biliary obstruction were not excluded from the indication. Factors including age, body weight, sex, clinical sign, disease, operative time, conversion to open surgery, perioperative complications, and postoperative hospital stay were investigated. The median age of the dogs was 11 years, and the median body weight was 5.4 kg. Fifty percent of the dogs exhibited no symptoms at the initial visit. Preoperative elevation of total bilirubin levels was observed in 16 dogs (21%). LC was successfully completed in 71 dogs (93%); the median operative time was 124 min. Although gall bladder ruptures were observed in 2 (2.6%) dogs, the operations were completed successfully. Three dogs (4.1%) had to be converted to open cholecystectomy and 2 (2.6%) underwent reoperation. Two dogs (2.6%) died intraoperatively and 2 (2.6%) died postoperatively. LC was a feasible, safe, and appropriate procedure considering the current operative indications for benign gall bladder diseases in dogs.
International Surgery | 2015
Mitsugu Kochi; Masashi Fujii; Ken Hagiwara; Hidenori Tamegai; Megumu Watanabe; Yoritaka Matsuno; Yuriko Takayama; Hiroshi Suda; Tadatoshi Takayama
Obstructing colorectal cancer (OCRC) is believed to indicate poorer long-term survival. The purpose of this study was to compare retrospectively perioperative safety and long-term results in patients undergoing surgery for OCRC following preoperative colonic decompression with that in those undergoing elective surgery alone for nonobstructing colorectal cancer (CRC). A total of 656 consecutive CRC patients undergoing colectomy between 2001 and 2011 at our institute were eligible for inclusion in the study. The patients were divided into an OCRC group, which included 104 patients undergoing colectomy with preoperative colonic decompression, and a CRC group, which included 552 patients undergoing colectomy alone. Morbidity, mortality, and prognosis were assessed. In the OCRC group, decompression was performed by nasointestinal tube in 42 patients (40.4%), transanal tube in 15 (14.4%), and colostomy in 47 (45.2%). The mortality rate was 0% in the OCRC group and 0.4% in the CRC group (2 of 552 patients). The morbidity rate was 44.8% in the OCRC group (48 of 104 patients) and 36.6% in the CRC group (202 of 552 patients). The 5-year overall survival rate was 69.5% in the OCRC group and 72.9% in the CRC group [hazard ratio 0.76; 95% confidence interval, 0.35 to 1.16; P = 0.48)]. No statistically significant difference in survival was observed between the 2 groups in stage II, III, or IV, or overall. No difference was observed in safety or survival between advanced OCRC patients undergoing preoperative colonic decompression and advanced non-obstructing CRC patients undergoing surgery alone.
Archive | 2014
Minoru Matsuda; Ken Hagiwara; Tadatoshi Takayama
In reduced port laparoscopic surgery (RPLS), insertion of the scope and instruments through the same port can cause interference. It is, thus, important to select theories and instruments that will minimize this interference. This chapter describes the scopes and devices that are currently available for use in RPLS (the development of a variety of new devices is also anticipated). Without a full understanding of these devices, surgeons in the field will be unable to perform RPLS safely and effectively. Sufficient preclinical training is strongly recommended before any of these devices are used clinically.
Cancer Chemotherapy and Pharmacology | 2013
Mitsugu Kochi; Yuji Akiyama; Tatsuya Aoki; Ken Hagiwara; Takao Takahashi; Katsuji Hironaka; Futoshi Teranishi; Fumihiko Osuka; Masahiro Takeuchi; Masashi Fujii; Toshifusa Nakajima
Hepato-gastroenterology | 2014
Ken Hagiwara; Mitsugu Kochi; Masashi Fujii; Keio Song; Hidenori Tamegai; Megumu Watanabe; Yuriko Takayama; Hiroshi Suda; Teshima Y; Tadatoshi Takayama
Nihon Rinsho Geka Gakkai Zasshi (journal of Japan Surgical Association) | 2012
Shigeoki Hayashi; Masahito Ikarashi; Ken Hagiwara; Motoo Yamagata; Tadatoshi Takayama; Takeki Suzuki
Hepato-gastroenterology | 2009
Mitsugu Kochi; Masashi Fujii; Noriaki Kanamori; Teruo Kaiga; Riki Okubo; Ken Hagiwara; Tomoya Funada; Hidenori Tamegai; Tadatoshi Takayama
Journal of Nihon University Medical Association | 2008
Motoo Yamagata; Tomohisa Kamo; Junko Sugiyama; Kazuo Sato; Yukie Morishita; Ken Hagiwara; Minoru Matsuda; Shigeoki Hayasi; Masashi Fujii; Tadatoshi Takayama
Nihon Rinsho Geka Gakkai Zasshi (journal of Japan Surgical Association) | 2005
Ken Hagiwara; Masaaki Hashizume; Hajime Tsunoda; Nao Yoshida; Tadahiko Kawaguchi
Journal of Nihon University Medical Association | 2018
Yoritaka Matsuno; Ken Hagiwara; Yuriko Isagawa; Taiki Miyakuni; Masahito Igarashi; Akira Kanamoto; Keio Sou; Shigeoki Hayashi; Tadatoshi Takayama